Login / Signup

Expanded clinical-grade membrane-bound IL-21/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo.

Xiang-Yu ZhaoQian JiangHao JiangLi-Juan HuTing ZhaoXing-Xing YuXiao-Jun Huang
Published in: European journal of immunology (2020)
Clinical-grade mbIL-21/4-1BBL-expanded NK cells exhibited antileukemic activity against AML in vitro and in vivo.
Keyphrases
  • nk cells
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • acute lymphoblastic leukemia